Source: Scientific Reports. Unidade: ICB
Subjects: FARMACOLOGIA, HIPERTENSÃO PULMONAR, AORTA DE ANIMAL, CAMUNDONGOS, CÉLULAS ENDOTELIAIS, MÚSCULO LISO VASCULAR, VASODILATAÇÃO, FÁRMACOS (SISTEMA CARDIOVASCULAR), MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOHAMED, Nura A. et al. Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Scientific Reports, v. 11, p. 8 , 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-83423-6. Acesso em: 16 ago. 2024.APA
Mohamed, N. A., Saleh, H. A., Kameno, Y., Marei, I., De Nucci, G., Shala, B. A., et al. (2021). Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Scientific Reports, 11, 8 . doi:10.1038/s41598-021-83423-6NLM
Mohamed NA, Saleh HA, Kameno Y, Marei I, De Nucci G, Shala BA, Shala F, Kirkby NS, Jennings L, Ansari DEA, Davies RP, Lickiss PD, Mitchell JA. Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension [Internet]. Scientific Reports. 2021 ; 11 8 .[citado 2024 ago. 16 ] Available from: https://doi.org/10.1038/s41598-021-83423-6Vancouver
Mohamed NA, Saleh HA, Kameno Y, Marei I, De Nucci G, Shala BA, Shala F, Kirkby NS, Jennings L, Ansari DEA, Davies RP, Lickiss PD, Mitchell JA. Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension [Internet]. Scientific Reports. 2021 ; 11 8 .[citado 2024 ago. 16 ] Available from: https://doi.org/10.1038/s41598-021-83423-6